Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. (Q47832529)
Jump to navigation
Jump to search
scientific article published on 9 July 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression. |
scientific article published on 9 July 2014 |
Statements
Serum interleukin-6 is a predictive biomarker for ketamine's antidepressant effect in treatment-resistant patients with major depression (English)
Jian-Jun Yang
Nan Wang
Chun Yang
Jin-Yun Shi